Activating Cannabinoid Receptors Worsened ADHD-Like Behaviors in Adolescent Rats, Especially Females

During adolescence, cannabinoid receptor activation aggravated hyperactivity and risky behaviors in ADHD model rats, with more pronounced effects in females. In adulthood, cannabinoid manipulation did not alter hyperactivity but worsened risk assessment. Gene expression of ECS components (CB1, CB2, FAAH, MAGL) was broadly increased in the prefrontal cortex of ADHD model animals.

Animal study using spontaneously hypertensive rats (SHR) as an ADHD model. Acute pharmacological manipulation of CB1 and CB2 receptors was performed during adolescence and adulthood. Locomotion and risk assessment were measured, and ECS gene expression and protein levels were analyzed in the prefrontal cortex.

Cannabis use is common among people with ADHD, sometimes as self-medication. This animal study suggests that cannabinoid receptor activation during adolescence could actually worsen ADHD-related behaviors, particularly in females, providing a cautionary note about adolescent cannabis use in the ADHD population.

ADHD and cannabis use frequently co-occur, and some individuals with ADHD report that cannabis helps with focus or restlessness. This study suggests the relationship may be more harmful than helpful, particularly during adolescence when the brain is still developing. The finding that the endocannabinoid system is altered in ADHD brains opens new avenues for understanding the disorder.

Used SHR rat model of ADHD, which has known limitations as an ADHD model. Acute pharmacological manipulation rather than chronic cannabis exposure. Direct CB1/CB2 agonists used, not THC. Cannot directly translate to human ADHD or cannabis use. Only examined two behavioral domains.